课题基金 / 基金详情

Error Prone DNA Synthesis and Oncogene Mutagensis

Error Prone DNA Synthesis and Oncogene Mutagensis
易错 DNA 合成和癌基因诱变
批准号:
6692676
负责人:
BERNARD S. STRAUSS
金额:
$15.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-05-01 至 2006-01-31

项目摘要

项目成果

BERNARD S. STRAUSS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (PROVIDED BY APPLICANT) There is evidence that "spontaneous" mutations in normal cells may result in large part from the operation of recently discovered mutagenic DNA polymerases rather than as a consequence of errors made by the major replicating system. Mutation is therefore the result of the interaction of the replicative and auxiliary DNA polymerases, the mismatch DNA repair system and the proofreading exonucleases. The different components may play more than one role, for example, as both structural and functional components of the replicative apparatus. It is the goal of the proposed work to determine the role of the auxiliary polymerases and to understand how they interact with the various components of the replication system. We wish to test the hypothesis that the mismatch repair proteins play a direct role in providing the auxiliary polymerases access to the DNA growing point. We want to determine the exact sites of interaction between the E. coli proofreading and DNA polymerase subunits and to understand how proofreading polymerization and mismatch repair interact. We propose to study the interactions between the polymerases and other relevant genes to determine how the cell "decides" which polymerase to use. We suppose that mutation in organisms is not an inevitable consequence of DNA replication. For unknown reasons, cells have arranged both to mutate and to control their mutation rate and have assigned particular enzymes to this job. If this view is confirmed, the error-prone polymerases provide an entirely new target for chemotherapy. Blocking the action of the error-prone polymerases should not stop replication. However, mutational cascades, such as those leading to tumor drug resistance, should be inhibited by such a block.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Hypermutability and silent mutations in human carcinogenesis.
人类致癌过程中的超突变和沉默突变。
DOI: 10.1006/scbi.1998.0092
发表时间: 1998
期刊: Seminars in cancer biology.
影响因子: --
作者: [Strauss,BS]
通讯作者: Strauss,BS
Cell death in Escherichia coli dnaE(Ts) mutants incubated at a nonpermissive temperature is prevented by mutation in the cydA gene.
在不允许的温度下孵育的大肠杆菌 dnaE(Ts) 突变体中的细胞死亡可以通过 cydA 基因的突变来防止。
DOI: 10.1128/jb.186.7.2147-2155.2004
发表时间: 2004
期刊: Journal of bacteriology
影响因子: 3.2
作者: [Strauss,Bernard, Kelly,Kemba, Dincman,Toros, Ekiert,Damian, Biesieda,Theresa, Song,Richard]
通讯作者: Song,Richard
ETIOLOGY OF TREATMENT-INDUCED SECONDARY LEUKEMIA
  • 批准号:
    3093778
  • 项目类别:
  • 资助金额:
    $12.5万
  • 财政年份:
    1991
  • 负责人:
    BERNARD S. STRAUSS
  • 依托单位:
CELLULAR CONTROL OF RESISTANCE TO ALKYLATING AGENTS
  • 批准号:
    3023288
  • 项目类别:
  • 资助金额:
    $1.26万
  • 财政年份:
    1991
  • 负责人:
    BERNARD S. STRAUSS
  • 依托单位:
ETIOLOGY OF TREATMENT - INDUCED SECONDARY LEUKEMIA
  • 批准号:
    3093776
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    1988
  • 负责人:
    BERNARD S. STRAUSS
  • 依托单位:
ETIOLOGY OF TREATMENT - INDUCED SECONDARY LEUKEMIA
  • 批准号:
    3093772
  • 项目类别:
  • 资助金额:
    $101.27万
  • 财政年份:
    1985
  • 负责人:
    BERNARD S. STRAUSS
  • 依托单位: